NEPHROS INC·4

Jan 8, 5:32 PM ET

Gwydir Tom 4

4 · NEPHROS INC · Filed Jan 8, 2021

Insider Transaction Report

Form 4
Period: 2021-01-06
Gwydir Tom
Director
Transactions
  • Award

    Common Stock

    2021-01-06+3,6666,031 total
  • Award

    Stock Option (right to buy)

    2021-01-06+6,8506,850 total
    Exercise: $8.06Exp: 2031-01-06Common Stock (6,850 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $5.31Exp: 2029-04-29Common Stock (9,627 underlying)
    9,627
  • Stock Option (right to buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
    5,568
Footnotes (4)
  • [F1]Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date.
  • [F2]This option vests as to 3,209 shares on each of 4/29/19, 4/29/20 and 4/29/21.
  • [F3]This option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.
  • [F4]Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT